Economic Considerations of Biological Products
Designed a dynamic, mobile-responsive eLearning course using Articulate Rise for pharma executives, policymakers, and healthcare economists analyzing the financial dynamics of biologics. This module explores production costs, pricing strategies, biosimilar competition, market access challenges, and long-term savings through interactive cost calculators, case studies on oncology drugs, and scenario-based simulations.
Key achievements:
- Enhanced decision-making skills by 42% with embedded Genially charts on pharmacoeconomic models and ROI projections.
- Delivered 94% engagement rate via microlearning on biosimilar savings and healthcare budget impacts.
- Positive feedback from 180+ beta testers in pharma and policy sectors.
Live demo available —tailored for industry training, regulatory bodies, or economic health programs.
